FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892887037> ?p ?o ?g. }

• W2892887037 endingPage "21" @default.
• W2892887037 startingPage "13" @default.
• W2892887037 abstract "Patients with large prostate glands are underrepresented in clinical trials incorporating brachytherapy due to concerns for excessive toxicity. We sought to compare health-related quality of life (HRQOL) outcomes between small (<60 cc) and large (≥60 cc) prostates treated with high-dose-rate brachytherapy (HDR-B).One hundred thirty patients at Emory University were treated with HDR-B monotherapy (n = 75) or HDR-B in combination with external beam radiation therapy (n = 55). American Urologic Association Symptom Score (AUASS) and expanded prostate cancer index composite for clinical practice (EPIC-CP) scores were recorded. A linear mixed model was performed dichotomizing prostate volume (<60 and ≥ 60 cc) with AUASS, individual EPIC-CP domains (urinary incontinence, urinary irritation/obstruction [UIO], bowel function, sexual function, and vitality/hormonal function), and overall EPIC-CP HRQOL scores.Median followup was 22.6 months (range 2.2-55.8). The median gland volume for the entire cohort (n = 130), <60 cc cohort (n = 104), and ≥60 cc cohort (n = 26) was 44 cc, 41.1 cc, and 68.0 cc, respectively. There were no baseline differences in HRQOL scores between cohorts. At 2 months, AUASS and UIO scores increased similarly between cohorts (AUASS p = 0.807; UIO p = 0.539), then decreased (longitudinal effect p < 0.001 and p = 0.005, respectively) to remain not significantly different at 12 months (AUASS p = 0.595; UIO p = 0.673). Overall, prostate volume was not significantly associated with change in AUASS (p = 0.403), urinary incontinence (p = 0.322), UIO symptoms (p = 0.779), bowel symptoms (p = 0.757), vitality/hormonal symptoms (p = 0.503), or overall HRQOL (p = 0.382).In appropriately selected patients, HDR-B appears well tolerated in patients with ≥60 cc prostate glands without an increase in patient-reported toxicity. Volume should not be a strict contraindication in those with adequate baseline function." @default.
• W2892887037 created "2018-10-05" @default.
• W2892887037 creator A5004417664 @default.
• W2892887037 creator A5008405410 @default.
• W2892887037 creator A5009839688 @default.
• W2892887037 creator A5013571534 @default.
• W2892887037 creator A5024852113 @default.
• W2892887037 creator A5033157355 @default.
• W2892887037 creator A5042210553 @default.
• W2892887037 creator A5064819717 @default.
• W2892887037 creator A5081519486 @default.
• W2892887037 creator A5087112738 @default.
• W2892887037 creator A5089966579 @default.
• W2892887037 date "2019-01-01" @default.
• W2892887037 modified "2023-09-27" @default.
• W2892887037 title "Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (≥60 cc) prostate glands" @default.
• W2892887037 cites W1179820463 @default.
• W2892887037 cites W1571792083 @default.
• W2892887037 cites W1756933029 @default.
• W2892887037 cites W1977296399 @default.
• W2892887037 cites W1988275108 @default.
• W2892887037 cites W2040103703 @default.
• W2892887037 cites W2047608066 @default.
• W2892887037 cites W2062313368 @default.
• W2892887037 cites W2062825069 @default.
• W2892887037 cites W2066640264 @default.
• W2892887037 cites W2080702549 @default.
• W2892887037 cites W2086604707 @default.
• W2892887037 cites W2101001966 @default.
• W2892887037 cites W2126781621 @default.
• W2892887037 cites W2140447194 @default.
• W2892887037 cites W2284090144 @default.
• W2892887037 cites W2524479840 @default.
• W2892887037 cites W2534674868 @default.
• W2892887037 cites W2548525236 @default.
• W2892887037 cites W2553678345 @default.
• W2892887037 cites W2610950887 @default.
• W2892887037 cites W2763207926 @default.
• W2892887037 cites W2178387498 @default.
• W2892887037 doi "https://doi.org/10.1016/j.brachy.2018.08.009" @default.
• W2892887037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30262410" @default.
• W2892887037 hasPublicationYear "2019" @default.
• W2892887037 type Work @default.
• W2892887037 sameAs 2892887037 @default.
• W2892887037 citedByCount "7" @default.
• W2892887037 countsByYear W28928870372020 @default.
• W2892887037 countsByYear W28928870372021 @default.
• W2892887037 countsByYear W28928870372022 @default.
• W2892887037 countsByYear W28928870372023 @default.
• W2892887037 crossrefType "journal-article" @default.
• W2892887037 hasAuthorship W2892887037A5004417664 @default.
• W2892887037 hasAuthorship W2892887037A5008405410 @default.
• W2892887037 hasAuthorship W2892887037A5009839688 @default.
• W2892887037 hasAuthorship W2892887037A5013571534 @default.
• W2892887037 hasAuthorship W2892887037A5024852113 @default.
• W2892887037 hasAuthorship W2892887037A5033157355 @default.
• W2892887037 hasAuthorship W2892887037A5042210553 @default.
• W2892887037 hasAuthorship W2892887037A5064819717 @default.
• W2892887037 hasAuthorship W2892887037A5081519486 @default.
• W2892887037 hasAuthorship W2892887037A5087112738 @default.
• W2892887037 hasAuthorship W2892887037A5089966579 @default.
• W2892887037 hasConcept C121608353 @default.
• W2892887037 hasConcept C126322002 @default.
• W2892887037 hasConcept C126894567 @default.
• W2892887037 hasConcept C159110408 @default.
• W2892887037 hasConcept C2775871022 @default.
• W2892887037 hasConcept C2776235491 @default.
• W2892887037 hasConcept C2777416452 @default.
• W2892887037 hasConcept C2778531004 @default.
• W2892887037 hasConcept C2779091618 @default.
• W2892887037 hasConcept C2779951463 @default.
• W2892887037 hasConcept C2780192828 @default.
• W2892887037 hasConcept C509974204 @default.
• W2892887037 hasConcept C71924100 @default.
• W2892887037 hasConcept C72563966 @default.
• W2892887037 hasConceptScore W2892887037C121608353 @default.
• W2892887037 hasConceptScore W2892887037C126322002 @default.
• W2892887037 hasConceptScore W2892887037C126894567 @default.
• W2892887037 hasConceptScore W2892887037C159110408 @default.
• W2892887037 hasConceptScore W2892887037C2775871022 @default.
• W2892887037 hasConceptScore W2892887037C2776235491 @default.
• W2892887037 hasConceptScore W2892887037C2777416452 @default.
• W2892887037 hasConceptScore W2892887037C2778531004 @default.
• W2892887037 hasConceptScore W2892887037C2779091618 @default.
• W2892887037 hasConceptScore W2892887037C2779951463 @default.
• W2892887037 hasConceptScore W2892887037C2780192828 @default.
• W2892887037 hasConceptScore W2892887037C509974204 @default.
• W2892887037 hasConceptScore W2892887037C71924100 @default.
• W2892887037 hasConceptScore W2892887037C72563966 @default.
• W2892887037 hasIssue "1" @default.
• W2892887037 hasLocation W28928870371 @default.
• W2892887037 hasLocation W28928870372 @default.
• W2892887037 hasOpenAccess W2892887037 @default.
• W2892887037 hasPrimaryLocation W28928870371 @default.
• W2892887037 hasRelatedWork W1952411274 @default.
• W2892887037 hasRelatedWork W1976392775 @default.
• W2892887037 hasRelatedWork W2048085960 @default.
• W2892887037 hasRelatedWork W2085529113 @default.

• next